MIR548V

Across TCGA pan-cancer cohorts, MIR548V RNA is linked to patient survival in 17 of 34 cancer types, making it the most broadly survival-associated MIR548V data layer.

The strongest signal is observed in testicular germ cell tumors (TGCT), where higher MIR548V RNA is associated with worse overall survival. In most high-consensus cancer types, elevated MIR548V expression acts as an unfavorable survival marker, although some lineages such as LUAD and HNSC show a favorable association.

TGCT, LUAD, and HNSC are the cancer types where MIR548V RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
TGCT	OS	Tertile	II,III,IV	0.505	1.000	<.001	78	view →
LUAD	OS	Median	All	0.443	0.273	.002	71	view →
HNSC	DFS	Tertile	IV	0.859	0.481	.004	66	view →
KIRP	DFS	Tertile	All	1.000	0.893	.010	36	view →
UCS	DFS	Tertile	All	0.820	0.207	.016	24	view →
CHOL	OS	Tertile	III,IV	0.275	0.886	.045	18	view →
CESC	DFS	Tertile	All	0.383	0.598	.002	18	view →
UVM	DFS	Tertile	All	1.000	0.486	.034	12	view →
THCA	DFS	Tertile	All	0.845	0.923	.015	12	view →
LUSC	DFS	Quartile	III,IV	0.740	0.431	.013	11	view →
PAAD	DFS	Quartile	All	0.339	0.518	.007	9	view →
SKCM	DFS	Tertile	IV	1.000	0.201	.047	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 17 lineages.

MIR548V–TGCT (OS)

Open the TGCT breakdown →